Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORM-12741 in Alzheimer's Disease
NCT01324518Phase 2Completed
- Sponsor
- Orion Corporation
- Start
- Apr 2011
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ORM-12741 in Alzheimer's disease (AD), sponsored by Orion Corporation. Started Apr 2011; status: completed.
02
Drugs
ORM-12741
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT01324518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01324518.